Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

Haemonetics (HAE) PT Lowered to $80 at Jefferies

November 10, 2021 8:10 AM EST

Jefferies analyst Anthony Petrone lowered the price target on Haemonetics (NYSE: HAE) to $80.00 (from $85.00) while maintaining a Buy rating.

The analyst commented, "Key updates from the call: 1) US plasma volumes improved to +20% (+14% last Q), 2) Nov volumes flat at +20% (high-end of revised... More

Haemonetics (HAE) Misses Q2 EPS by 1c, Lowers FY EPS Guidance

November 9, 2021 6:23 AM EST

Haemonetics (NYSE: HAE) reported Q2 EPS of $0.60, $0.01 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $239.9 million versus the consensus estimate of $239.99 million.

GUIDANCE:

Haemonetics sees FY2022 EPS of $2.40-$2.65, versus the consensus of $2.76.

For earnings history and earnings-related data on Haemonetics (HAE) click here.

... More